药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Fenoterol
Melengestrol
The risk or severity of adverse effects can be increased when Carfilzomib is combined with Melengestrol.
Fenoterol
Dexamethasone isonicotinate
The risk or severity of adverse effects can be increased when Carfilzomib is combined with Dexamethasone isonicotinate.
Fenoterol
Tepoxalin
The risk or severity of adverse effects can be increased when Carfilzomib is combined with Tepoxalin.
Fenoterol
Meprednisone
The risk or severity of adverse effects can be increased when Carfilzomib is combined with Meprednisone.
Fenoterol
Fluprednisolone
The risk or severity of adverse effects can be increased when Carfilzomib is combined with Fluprednisolone.
Fenoterol
Antilymphocyte immunoglobulin (horse)
The risk or severity of adverse effects can be increased when Carfilzomib is combined with Antilymphocyte immunoglobulin (horse).
Fenoterol
Peginterferon beta-1a
The risk or severity of adverse effects can be increased when Carfilzomib is combined with Peginterferon beta-1a.
Fenoterol
Tixocortol
The risk or severity of adverse effects can be increased when Carfilzomib is combined with Tixocortol.
Fenoterol
Vilanterol
The risk or severity of adverse effects can be increased when Carfilzomib is combined with Vilanterol.
Fenoterol
Dinutuximab
The risk or severity of adverse effects can be increased when Carfilzomib is combined with Dinutuximab.
Fenoterol
Olaparib
The risk or severity of adverse effects can be increased when Carfilzomib is combined with Olaparib.
Fenoterol
Idelalisib
The risk or severity of adverse effects can be increased when Carfilzomib is combined with Idelalisib.
Fenoterol
Ibrutinib
The risk or severity of adverse effects can be increased when Carfilzomib is combined with Ibrutinib.
Fenoterol
Blinatumomab
The risk or severity of adverse effects can be increased when Carfilzomib is combined with Blinatumomab.
Fenoterol
Siltuximab
The risk or severity of adverse effects can be increased when Carfilzomib is combined with Siltuximab.
Fenoterol
Vedolizumab
The risk or severity of adverse effects can be increased when Carfilzomib is combined with Vedolizumab.
Fenoterol
Secukinumab
The risk or severity of adverse effects can be increased when Carfilzomib is combined with Secukinumab.
Fenoterol
Fluprednidene
The risk or severity of adverse effects can be increased when Carfilzomib is combined with Fluprednidene.
Fenoterol
Obinutuzumab
The risk or severity of adverse effects can be increased when Carfilzomib is combined with Obinutuzumab.
Fenoterol
Dimethyl fumarate
The risk or severity of adverse effects can be increased when Carfilzomib is combined with Dimethyl fumarate.